{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:12:53Z","timestamp":1767093173974},"reference-count":36,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.3892\/or.2012.2071","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T10:52:43Z","timestamp":1349434363000},"page":"321-328","source":"Crossref","is-referenced-by-count":11,"title":["Ex vivo1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients"],"prefix":"10.3892","volume":"29","author":[{"given":"YORAM","family":"ABRAMOV","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHANI","family":"CARMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHAOUL O.","family":"ANTEBY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ISRAEL","family":"RINGEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"key":"key20180107214612_b1-or-29-01-0321","unstructured":"National Cancer Institutehttp:\/\/www.cancer.gov"},{"key":"key20180107214612_b2-or-29-01-0321","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"key20180107214612_b3-or-29-01-0321","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/carcin\/bgp070","article-title":"Metabolic transformation in cancer","volume":"30","author":"Tennant","year":"2009","journal-title":"Carcinogenesis"},{"key":"key20180107214612_b4-or-29-01-0321","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"key20180107214612_b5-or-29-01-0321","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107214612_b6-or-29-01-0321","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0958-1669(95)80031-X","article-title":"Nuclear magnetic resonance analysis of cell metabolism","volume":"6","author":"Zupke","year":"1995","journal-title":"Curr Opin Biotechnol"},{"key":"key20180107214612_b7-or-29-01-0321","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/(SICI)1099-1492(1998110)11:7<354::AID-NBM515>3.0.CO;2-N","article-title":"Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours","volume":"11","author":"Bel","year":"1998","journal-title":"NMR Biomed"},{"key":"key20180107214612_b8-or-29-01-0321","first-page":"7536","article-title":"Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study","volume":"61","author":"Sterin","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107214612_b9-or-29-01-0321","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1731::AID-CNCR20>3.0.CO;2-4","article-title":"1H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumors","volume":"82","author":"Massuger","year":"1998","journal-title":"Cancer"},{"key":"key20180107214612_b10-or-29-01-0321","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1099-1492(200008)13:5<297::AID-NBM648>3.0.CO;2-I","article-title":"High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid","volume":"13","author":"Boss","year":"2000","journal-title":"NMR Biomed"},{"key":"key20180107214612_b11-or-29-01-0321","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U","article-title":"Tumour phospholipid metabolism","volume":"12","author":"Podo","year":"1999","journal-title":"NMR Biomed"},{"key":"key20180107214612_b12-or-29-01-0321","first-page":"1","volume-title":"Nuclear Magnetic Resonance Spectroscopy in the Study of Neoplastic Tissue","author":"Tosi","year":"2005"},{"key":"key20180107214612_b13-or-29-01-0321","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.bioeng.7.060804.100411","article-title":"In vivo magnetic resonance spectroscopy in cancer","volume":"7","author":"Gillies","year":"2005","journal-title":"Annu Rev Biomed Eng"},{"key":"key20180107214612_b14-or-29-01-0321","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1470-2045(06)70905-6","article-title":"Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer","volume":"7","author":"Kwock","year":"2006","journal-title":"Lancet Oncol"},{"key":"key20180107214612_b15-or-29-01-0321","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1525-1438.1995.05030211.x","article-title":"Characterization of human ovarian epithelial tumors (ex vivo) by proton magnetic resonance spectroscopy","volume":"5","author":"Mackinnon","year":"1995","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107214612_b16-or-29-01-0321","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/mrm.1910380411","article-title":"Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis","volume":"38","author":"Wallace","year":"1997","journal-title":"Magn Reson Med"},{"key":"key20180107214612_b17-or-29-01-0321","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-10-1434","article-title":"Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers","volume":"16","author":"Slupsky","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107214612_b18-or-29-01-0321","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/nbm.1658","article-title":"MR evaluation of response to targeted treatment in cancer cells","volume":"24","author":"Podo","year":"2011","journal-title":"NMR Biomed"},{"key":"key20180107214612_b19-or-29-01-0321","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/jnci\/94.16.1197","article-title":"Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions","volume":"94","author":"Katz-Brull","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"key20180107214612_b20-or-29-01-0321","first-page":"80","article-title":"Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells","volume":"59","author":"Aboagye","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107214612_b21-or-29-01-0321","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-03-3829","article-title":"Molecular causes of the aberrant choline phospholipid metabolism in breast cancer","volume":"64","author":"Glunde","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107214612_b22-or-29-01-0321","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mrm.10295","article-title":"Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin","volume":"48","author":"Glunde","year":"2002","journal-title":"Magn Reson Med"},{"key":"key20180107214612_b23-or-29-01-0321","first-page":"3599","article-title":"Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells","volume":"61","author":"Ackerstaff","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107214612_b24-or-29-01-0321","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1158\/0008-5472.CAN-05-1146","article-title":"Alterations of choline phospholipid metabolism in ovarian tumor progression","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107214612_b25-or-29-01-0321","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/nbm.1779","article-title":"Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging","volume":"25","author":"Canese","year":"2012","journal-title":"NMR Biomed"},{"key":"key20180107214612_b26-or-29-01-0321","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/RLI.0b013e31821690ef","article-title":"In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy","volume":"46","author":"Esseridou","year":"2011","journal-title":"Invest Radiol"},{"key":"key20180107214612_b27-or-29-01-0321","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1158\/0008-5472.CAN-09-3833","article-title":"Activation of phosphtidylcholine cycle enzymes in human epithelial ovarian cancer cells","volume":"70","author":"Iorio","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107214612_b28-or-29-01-0321","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/jmre.1998.1578","article-title":"Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy","volume":"135","author":"Cheng","year":"1998","journal-title":"J Magn Reson"},{"key":"key20180107214612_b29-or-29-01-0321","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mrm.21694","article-title":"Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues","volume":"60","author":"Tessem","year":"2008","journal-title":"Magn Reson Med"},{"key":"key20180107214612_b30-or-29-01-0321","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0360-3016(01)01630-3","article-title":"Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer","volume":"51","author":"Brizel","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107214612_b31-or-29-01-0321","first-page":"916","article-title":"High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers","volume":"60","author":"Walenta","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107214612_b32-or-29-01-0321","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2867-3-5","article-title":"NMR studies of the relationship between the changes of membrane lipids and the cisplatin resistance of A549\/DDP cells","volume":"3","author":"Huang","year":"2003","journal-title":"Cancer Cell Int"},{"key":"key20180107214612_b33-or-29-01-0321","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/0959-8049(94)00338-6","article-title":"Effects of the microtubule-disturbing agents docetaxel (Taxotere), vinblastine and vincristine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitro","volume":"30A","author":"Hanauske","year":"1994","journal-title":"Eur J Cancer"},{"key":"key20180107214612_b34-or-29-01-0321","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1073\/pnas.90.2.447","article-title":"Phospholipid transmembrane domains and lateral diffusion in fibroblasts","volume":"90","author":"Chahine","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107214612_b35-or-29-01-0321","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0092-8674(80)90623-6","article-title":"Influence of cytoskeletal assembly on phosphatidylcholine synthesis in intact phagocytic cells","volume":"20","author":"Pike","year":"1980","journal-title":"Cell"},{"key":"key20180107214612_b36-or-29-01-0321","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-8993(99)01570-X","article-title":"Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity","volume":"834","author":"Fallbrook","year":"1999","journal-title":"Brain Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2071\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T13:28:17Z","timestamp":1594733297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,10,5]]},"published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.3892\/or.2012.2071"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2071","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,5]]}}}